Rectal cancer
Not recruitingStudy on Chemotherapy and Pelvic Reirradiation for Patients with Recurrent Rectal Cancer Using Irinotecan, Levoleucovorin, Fluorouracil, Oxaliplatin, and Capecitabine
Study on Chemotherapy and Pelvic Reirradiation for Patients with Recurrent Rectal Cancer Using Irinotecan, Levoleucovorin, Fluorouracil, Oxaliplatin, and Capecitabine
- Disease:Rectal cancer
- Substances:CapecitabineFluorouracil+3
France- Participants:18–64 years · 65+ years
- Substances:Capecitabine
- Sponsor:Centre Hospitalier Universitaire De Bordeaux





